The Use of Medical Marijuana in Cancer
- 23 May 2016
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Oncology Reports
- Vol. 18 (7)
- https://doi.org/10.1007/s11912-016-0530-0
Abstract
The use of medical marijuana in cancer care presents a dilemma for both patients and physicians. The scientific evidence is evolving, yet much of the known information is still insufficient to adequately inform patients as to risks and benefits. In addition, evidence-based dosing and administration information on medical marijuana is lacking. Medical marijuana is now legal, on some level, in 24 states plus the District of Columbia, yet is not legal on the federal level. This review addresses the current state of the research, including potential indications, risks and adverse effects, preliminary data on anticancer effects, as well as legal and quality issues. A summary of the clinical trials underway on medical marijuana in the oncology setting is discussed.Keywords
This publication has 19 references indexed in Scilit:
- Association Between Cannabis Use and the Risk of Bladder Cancer: Results From the California Men's Health StudyUrology, 2015
- Inhaled medicinal cannabis and the immunocompromised patientSupportive Care in Cancer, 2014
- Marijuana and lung diseasesCurrent Opinion in Pulmonary Medicine, 2014
- Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic reviewDrug Metabolism Reviews, 2013
- Marijuana use and risk of lung cancer: a 40-year cohort studyCancer Causes & Control, 2013
- An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid AnalgesicsJournal of Pain and Symptom Management, 2012
- Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose TrialThe Journal of Pain, 2012
- A Combined Preclinical Therapy of Cannabinoids and Temozolomide against GliomaMolecular Cancer Therapeutics, 2011
- Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related PainJournal of Pain and Symptom Management, 2010
- A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae)American Journal of Botany, 2004